What is the treatment for wheezing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Wheezing

For acute wheezing, administer nebulized albuterol 5 mg (or 0.15 mg/kg) or terbutaline 10 mg (or 0.3 mg/kg), with oxygen as the driving gas whenever possible, and add systemic corticosteroids (prednisolone 2 mg/kg/day for 3 days, max 40 mg/day, or hydrocortisone 100 mg IV every 6 hours). 1

Acute Severe Wheezing/Asthma

Initial Assessment and Treatment

Severity indicators requiring immediate treatment: 1

  • Unable to complete sentences in one breath
  • Respiratory rate ≥25/min (adults) or ≥50/min (children)
  • Heart rate ≥110/min (adults) or ≥140/min (children)
  • Peak expiratory flow (PEF) ≤50% predicted or best

First-line bronchodilator therapy: 1

  • Nebulized salbutamol 5 mg or terbutaline 10 mg (adults)
  • Nebulized salbutamol 5 mg (0.15 mg/kg) or terbutaline 10 mg (0.3 mg/kg) (children)
  • Repeat every 20-30 minutes initially if improving, then 4-6 hourly 1
  • Oxygen should drive the nebulizer at 6-8 L/min whenever possible 1

Alternative delivery method: 1

  • MDI with spacer: salbutamol 100 mcg per actuation, repeat up to 20 times
  • Research supports that high-dose albuterol via MDI plus spacer (50 mcg/kg) is equivalent to nebulization (150 mcg/kg) and better tolerated in children 2

Escalation for Poor Response

If inadequate response after initial bronchodilator: 1

  • Add ipratropium bromide 250-500 mcg nebulized to the beta-agonist
  • Continue combination therapy every 30-60 minutes as needed
  • Consider hospital admission

Systemic corticosteroids (mandatory for acute severe wheezing): 1

  • Prednisolone 2 mg/kg/day for 3 days (maximum 40 mg/day), OR
  • Hydrocortisone 100 mg IV every 6 hours

Life-threatening features requiring ICU consideration: 1

  • PEF <33% predicted
  • Silent chest, cyanosis, or feeble respiratory effort
  • Bradycardia, hypotension, exhaustion, confusion, or coma
  • Consider aminophylline IV: 5 mg/kg loading dose over 20 minutes (omit if already on theophylline), then 1 mg/kg/hour infusion 1

Chronic/Persistent Wheezing

Stepwise Approach

For chronic persistent wheezing, optimize hand-held inhaler therapy first before considering nebulizers: 1

  • Try salbutamol 200-400 mcg QID or terbutaline 500-1000 mcg QID via MDI
  • If inadequate, increase to salbutamol 1000 mcg QID and/or ipratropium 160-240 mcg QID 1

Nebulized therapy for chronic asthma (Step 4 or above only): 1

  • Should only be prescribed after demonstrating ≥15% improvement in peak flow over baseline during a 2-week home trial 1
  • Typical doses: salbutamol 2.5 mg QID or terbutaline 5 mg QID, with or without ipratropium 250-500 mcg 1

Regular inhaled corticosteroids are superior to PRN bronchodilators alone: 3

  • Regular beclomethasone 400 mcg BID plus PRN salbutamol resulted in 69.6% symptom-free days vs 61.0% with PRN salbutamol alone (P=0.034) 3
  • However, PRN combination beclomethasone/salbutamol may be an alternative with similar efficacy but lower cumulative steroid dose 4, 3

Persistent Wheezing Despite Treatment

Diagnostic Evaluation

For infants/children with persistent wheezing despite bronchodilators and corticosteroids, consider flexible bronchoscopy with: 1

  • Airway survey to identify anatomic abnormalities (found in ~33% of cases, with >90% showing improvement either spontaneously or with surgical correction)
  • Bronchoalveolar lavage (BAL) to identify bacterial infection (positive in 40-60% of cases, with 20-30% improving with antibiotic treatment)

Important caveat: Beta-agonists may worsen airway dynamics in infants with airway malacia, so identification of this condition changes management 1

Special Populations

Preschool Children (1-4 years)

  • Nebulized albuterol 2.5 mg (0.15 mg/kg) is standard 5
  • Children <15 kg require dose adjustment using 0.5% solution rather than 0.083% 5
  • Spacer devices are better tolerated and equally effective 2

Brittle Asthma

  • Patients with sudden severe attacks require high-dose beta-agonist by nebulizer (salbutamol 5 mg or terbutaline 10 mg) 1
  • Should have written treatment plan agreed with specialist 1

Elderly Patients

  • Beta-agonists may precipitate angina; first treatment should be supervised 1
  • Use mouthpiece rather than mask with ipratropium to avoid glaucoma exacerbation 1

Common Pitfalls

  • Do not use ribavirin for RSV bronchiolitis—it does not reduce hospital stay, oxygen need, or ventilation requirements 1
  • Avoid empiric food avoidance in infants without eczema—no evidence supports this for wheezing 1
  • Do not continue ineffective therapy—if previously effective treatment fails, this signals worsening disease requiring reassessment 5
  • Ensure proper nebulizer technique—treatment should take 5-15 minutes; if slower, check equipment 1, 5

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.